HK Stock MarketDetailed Quotes

01513 LIVZON PHARMA

Watchlist
  • 26.700
  • -0.300-1.11%
Market Closed Apr 25 16:08 CST
24.33BMarket Cap10.74P/E (TTM)

LIVZON PHARMA Key Stats

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2025
(FY)Dec 31, 2024
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
Turnover
-1.92%3.18B
-4.97%11.81B
-5.94%9.08B
-6.09%6.28B
-4.99%3.24B
-1.58%12.43B
1.76%9.65B
6.15%6.69B
-1.90%3.41B
4.69%12.63B
Operating income
-1.92%3.18B
-4.97%11.81B
-5.94%9.08B
-6.09%6.28B
-4.99%3.24B
-1.58%12.43B
1.76%9.65B
6.15%6.69B
-1.90%3.41B
4.69%12.63B
Operating expenses
2.72%-1.11B
8.61%-4.08B
10.84%-3.1B
10.99%-2.14B
9.10%-1.15B
-0.09%-4.47B
-6.42%-3.48B
-9.61%-2.4B
-7.03%-1.26B
-4.90%-4.46B
Gross profit
-1.48%2.07B
-2.93%7.73B
-3.17%5.98B
-3.35%4.14B
-2.58%2.1B
-2.49%7.96B
-0.70%6.17B
4.30%4.29B
-6.46%2.15B
4.58%8.17B
Selling expenses
8.69%-800.02M
9.55%-3.25B
12.73%-2.46B
11.57%-1.74B
9.20%-876.11M
7.44%-3.6B
3.03%-2.81B
-3.35%-1.97B
12.80%-964.91M
-0.09%-3.89B
Administrative expenses
20.17%-153.81M
6.30%-613.06M
2.95%-472.58M
-6.43%-330.94M
-28.75%-192.68M
0.39%-654.27M
12.23%-486.96M
12.38%-310.93M
24.94%-149.65M
1.10%-656.86M
Research and development expenses
9.28%-216.08M
22.58%-1.03B
25.49%-734.49M
19.67%-490.66M
23.52%-238.17M
6.44%-1.33B
-0.72%-985.76M
-10.15%-610.78M
-8.00%-311.41M
-24.51%-1.43B
Profit from asset sales
-128.09%-86.13K
26,621.05%45.2M
-85.45%-370.4K
76.71%-76.44K
--306.57K
-119.80%-170.44K
-117.81%-199.73K
35.71%-328.23K
----
-87.77%860.66K
Revaluation surplus
-46.59%826.05K
39.81%-15.44M
86.90%-5.5M
43.33%-18.39M
105.96%1.55M
65.92%-25.65M
46.35%-41.99M
63.45%-32.45M
51.49%-25.95M
-226.89%-75.27M
-Changes in the fair value of other assets
-46.59%826.05K
39.81%-15.44M
86.90%-5.5M
43.33%-18.39M
105.96%1.55M
65.92%-25.65M
46.35%-41.99M
63.45%-32.45M
51.49%-25.95M
-226.89%-75.27M
Impairment and provision
-32.89%-12.95M
41.58%-188.76M
51.86%-61.12M
38.68%-32.35M
15.15%-9.74M
-164.17%-323.1M
2.09%-126.95M
-72.01%-52.76M
-154.10%-11.48M
-90.17%-122.31M
-Other impairment is provision
-32.89%-12.95M
41.58%-188.76M
51.86%-61.12M
38.68%-32.35M
15.15%-9.74M
-164.17%-323.1M
2.09%-126.95M
-72.01%-52.76M
-154.10%-11.48M
-90.17%-122.31M
Special items of operating profit
25.62%55.74M
-40.01%159.92M
-29.88%119.09M
-51.94%73.54M
-45.08%44.37M
17.21%266.6M
12.19%169.85M
28.50%153.02M
8.80%80.8M
-23.59%227.46M
Operating profit
13.66%902.88M
25.42%2.69B
27.66%2.26B
10.65%1.53B
8.89%794.38M
2.97%2.14B
9.41%1.77B
12.80%1.39B
6.41%729.54M
-5.24%2.08B
Financing cost
2.81%56.04M
-42.58%155.89M
-74.63%54.93M
87.18%77.59M
522.72%54.51M
1.02%271.5M
-14.83%216.48M
-56.60%41.45M
-76.92%8.75M
283.72%268.76M
Adjustment items of  earning before tax
92.46%-335.4K
-17.92%-38.25M
26.66%-12.56M
23.33%-3.88M
-55.83%-4.45M
-62.17%-32.44M
-152.29%-17.13M
-96.25%-5.06M
-1,081.96%-2.85M
6.08%-20.01M
Earning before tax
13.52%958.59M
17.77%2.81B
16.89%2.3B
13.00%1.61B
14.82%844.44M
2.24%2.38B
5.59%1.97B
7.62%1.42B
1.61%735.44M
3.78%2.33B
Tax
-20.71%-154.95M
-3.42%-501.66M
-3.23%-356.96M
-1.76%-253.69M
-5.58%-128.36M
-29.36%-485.07M
-13.19%-345.79M
-21.57%-249.3M
-7.91%-121.58M
-27.72%-374.97M
After-tax profit from continuing operations
12.23%803.64M
21.44%2.3B
19.80%1.95B
15.38%1.35B
16.65%716.08M
-2.96%1.9B
4.10%1.62B
5.06%1.17B
0.45%613.86M
0.18%1.96B
Earning after tax
12.23%803.64M
21.44%2.3B
19.80%1.95B
15.38%1.35B
16.65%716.08M
-2.96%1.9B
4.10%1.62B
5.06%1.17B
0.45%613.86M
0.18%1.96B
Minority profit
54.20%166.93M
534.24%243.39M
1,099.85%273.16M
365.13%183.73M
238.80%108.26M
-221.40%-56.05M
-57.47%22.77M
-60.48%39.5M
-44.75%31.95M
-73.83%46.17M
Profit attributable to shareholders
4.75%636.71M
5.50%2.06B
4.44%1.67B
3.21%1.17B
4.45%607.82M
2.32%1.95B
6.29%1.6B
11.50%1.13B
5.17%581.91M
7.53%1.91B
Basic earnings per share
9.23%0.71
6.67%2.24
5.23%1.81
4.10%1.27
4.84%0.65
2.94%2.1
6.83%1.72
11.93%1.22
5.08%0.62
7.37%2.04
Diluted earnings per share
9.23%0.71
6.67%2.24
5.23%1.81
4.10%1.27
4.84%0.65
2.94%2.1
6.83%1.72
11.93%1.22
5.08%0.62
7.37%2.04
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified Opinion
--
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion
Auditor
--
Grant Thornton Certified Public Accountants (Special General Partnership)
--
--
--
Grant Thornton Certified Public Accountants (Special General Partnership)
--
--
--
Grant Thornton Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2025(FY)Dec 31, 2024(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022
Turnover -1.92%3.18B-4.97%11.81B-5.94%9.08B-6.09%6.28B-4.99%3.24B-1.58%12.43B1.76%9.65B6.15%6.69B-1.90%3.41B4.69%12.63B
Operating income -1.92%3.18B-4.97%11.81B-5.94%9.08B-6.09%6.28B-4.99%3.24B-1.58%12.43B1.76%9.65B6.15%6.69B-1.90%3.41B4.69%12.63B
Operating expenses 2.72%-1.11B8.61%-4.08B10.84%-3.1B10.99%-2.14B9.10%-1.15B-0.09%-4.47B-6.42%-3.48B-9.61%-2.4B-7.03%-1.26B-4.90%-4.46B
Gross profit -1.48%2.07B-2.93%7.73B-3.17%5.98B-3.35%4.14B-2.58%2.1B-2.49%7.96B-0.70%6.17B4.30%4.29B-6.46%2.15B4.58%8.17B
Selling expenses 8.69%-800.02M9.55%-3.25B12.73%-2.46B11.57%-1.74B9.20%-876.11M7.44%-3.6B3.03%-2.81B-3.35%-1.97B12.80%-964.91M-0.09%-3.89B
Administrative expenses 20.17%-153.81M6.30%-613.06M2.95%-472.58M-6.43%-330.94M-28.75%-192.68M0.39%-654.27M12.23%-486.96M12.38%-310.93M24.94%-149.65M1.10%-656.86M
Research and development expenses 9.28%-216.08M22.58%-1.03B25.49%-734.49M19.67%-490.66M23.52%-238.17M6.44%-1.33B-0.72%-985.76M-10.15%-610.78M-8.00%-311.41M-24.51%-1.43B
Profit from asset sales -128.09%-86.13K26,621.05%45.2M-85.45%-370.4K76.71%-76.44K--306.57K-119.80%-170.44K-117.81%-199.73K35.71%-328.23K-----87.77%860.66K
Revaluation surplus -46.59%826.05K39.81%-15.44M86.90%-5.5M43.33%-18.39M105.96%1.55M65.92%-25.65M46.35%-41.99M63.45%-32.45M51.49%-25.95M-226.89%-75.27M
-Changes in the fair value of other assets -46.59%826.05K39.81%-15.44M86.90%-5.5M43.33%-18.39M105.96%1.55M65.92%-25.65M46.35%-41.99M63.45%-32.45M51.49%-25.95M-226.89%-75.27M
Impairment and provision -32.89%-12.95M41.58%-188.76M51.86%-61.12M38.68%-32.35M15.15%-9.74M-164.17%-323.1M2.09%-126.95M-72.01%-52.76M-154.10%-11.48M-90.17%-122.31M
-Other impairment is provision -32.89%-12.95M41.58%-188.76M51.86%-61.12M38.68%-32.35M15.15%-9.74M-164.17%-323.1M2.09%-126.95M-72.01%-52.76M-154.10%-11.48M-90.17%-122.31M
Special items of operating profit 25.62%55.74M-40.01%159.92M-29.88%119.09M-51.94%73.54M-45.08%44.37M17.21%266.6M12.19%169.85M28.50%153.02M8.80%80.8M-23.59%227.46M
Operating profit 13.66%902.88M25.42%2.69B27.66%2.26B10.65%1.53B8.89%794.38M2.97%2.14B9.41%1.77B12.80%1.39B6.41%729.54M-5.24%2.08B
Financing cost 2.81%56.04M-42.58%155.89M-74.63%54.93M87.18%77.59M522.72%54.51M1.02%271.5M-14.83%216.48M-56.60%41.45M-76.92%8.75M283.72%268.76M
Adjustment items of  earning before tax 92.46%-335.4K-17.92%-38.25M26.66%-12.56M23.33%-3.88M-55.83%-4.45M-62.17%-32.44M-152.29%-17.13M-96.25%-5.06M-1,081.96%-2.85M6.08%-20.01M
Earning before tax 13.52%958.59M17.77%2.81B16.89%2.3B13.00%1.61B14.82%844.44M2.24%2.38B5.59%1.97B7.62%1.42B1.61%735.44M3.78%2.33B
Tax -20.71%-154.95M-3.42%-501.66M-3.23%-356.96M-1.76%-253.69M-5.58%-128.36M-29.36%-485.07M-13.19%-345.79M-21.57%-249.3M-7.91%-121.58M-27.72%-374.97M
After-tax profit from continuing operations 12.23%803.64M21.44%2.3B19.80%1.95B15.38%1.35B16.65%716.08M-2.96%1.9B4.10%1.62B5.06%1.17B0.45%613.86M0.18%1.96B
Earning after tax 12.23%803.64M21.44%2.3B19.80%1.95B15.38%1.35B16.65%716.08M-2.96%1.9B4.10%1.62B5.06%1.17B0.45%613.86M0.18%1.96B
Minority profit 54.20%166.93M534.24%243.39M1,099.85%273.16M365.13%183.73M238.80%108.26M-221.40%-56.05M-57.47%22.77M-60.48%39.5M-44.75%31.95M-73.83%46.17M
Profit attributable to shareholders 4.75%636.71M5.50%2.06B4.44%1.67B3.21%1.17B4.45%607.82M2.32%1.95B6.29%1.6B11.50%1.13B5.17%581.91M7.53%1.91B
Basic earnings per share 9.23%0.716.67%2.245.23%1.814.10%1.274.84%0.652.94%2.16.83%1.7211.93%1.225.08%0.627.37%2.04
Diluted earnings per share 9.23%0.716.67%2.245.23%1.814.10%1.274.84%0.652.94%2.16.83%1.7211.93%1.225.08%0.627.37%2.04
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified Opinion------Unqualified Opinion------Unqualified Opinion
Auditor --Grant Thornton Certified Public Accountants (Special General Partnership)------Grant Thornton Certified Public Accountants (Special General Partnership)------Grant Thornton Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

HK Dividend Stocks HK Dividend Stocks

Dividend stocks are stocks of companies in the HK stock market that regularly distribute dividends to shareholders, generally representing stable businesses. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK dividend stocks, ranked from highest to lowest based on real-time market data. Dividend stocks are stocks of companies in the HK stock market that regularly distribute dividends to shareholders, generally representing stable businesses. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in HK dividend stocks, ranked from highest to lowest based on real-time market data.

Unlock Now